loading

Cellectar Biosciences Inc Azioni (CLRB) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
30.27%
2.3898
3.4271 6.2092 5.4935 7.3455
Costs And Expenses
5.68%
6.0375
6.401 12.74 13.33 13.70
Operating Income/Loss
5.68%
-6.0375
-6.401 -12.74 -13.33 -13.70
Nonoperating Income/Loss
390.40%
0.5896
-0.203 10.46 -1.337 12.78
Income/Loss From Continuing Operations Before Tax
8.58%
-6.0375
-6.604 -5.4826 -13.33 -0.9194
Income/Loss From Continuing Operations After Tax
17.51%
-5.4479
-6.604 -2.3554 -14.66 -0.9194
Net Income/Loss
17.51%
-5.4479
-6.604 -2.3554 -14.66 -0.9194
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
96.51%
1.6088
46.08 1.772 39.34 35.82
Diluted Average Shares
96.51%
1.6088
46.08 1.5983 39.79 37.45
Basic Earnings Per Share
2,321%
-3.39
-0.14 -0.01 -0.37 -0.03
Diluted Earnings Per Share
2,321%
-3.39
-0.14 -0.01 -0.40 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.96
price up icon 0.28%
$27.08
price up icon 4.60%
$23.52
price down icon 1.34%
$100.42
price down icon 0.67%
$143.50
price down icon 1.24%
biotechnology ONC
$336.26
price up icon 1.27%
Capitalizzazione:     |  Volume (24 ore):